U.S. Food and Drug Administration Sustainability Profile
The U.S. Food and Drug Administration (FDA), headquartered in Silver Spring, Maryland, plays a pivotal role in safeguarding public health across the United States. Established in 1906, the FDA has evolved significantly, overseeing a vast array of products, including food, pharmaceuticals, medical devices, and cosmetics. With a commitment to ensuring the safety and efficacy of these products, the FDA employs rigorous scientific evaluation and regulatory processes. Its unique position as a federal agency allows it to implement standards that protect consumers while fostering innovation in the healthcare and food industries. Notable achievements include the introduction of the Food Safety Modernization Act and the rapid approval of COVID-19 vaccines, highlighting the FDA's responsiveness to public health needs. As a leader in regulatory science, the FDA continues to shape the landscape of health and safety in the U.S. and beyond.
DitchCarbon Score
How does U.S. Food and Drug Administration's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Food Product Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
U.S. Food and Drug Administration's score of 13 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
U.S. Food and Drug Administration's reported carbon emissions
The U.S. Food and Drug Administration (FDA) currently does not have publicly available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the agency. This lack of data suggests that the FDA may not have established formal commitments to reduce carbon emissions or may not publicly disclose such information. In the context of climate initiatives, the FDA's emissions data is not cascaded from any parent organisation, indicating that it operates independently regarding its climate impact reporting. As such, the FDA's current stance on carbon emissions and climate commitments remains unclear, with no specific targets or achievements to report.
How Carbon Intensive is U.S. Food and Drug Administration's Industry?
How Carbon Intensive is U.S. Food and Drug Administration's Location?
U.S. Food and Drug Administration's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
U.S. Food and Drug Administration has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
